newsfilter
← Latest News
FDA Approved Drugs·

Approval of Imitrex, Nda #020132 (Labeling)

Approval Date: 12/09/2025; Drug Name: Imitrex, Nda #020132; Active Ingredients: SUMATRIPTAN SUCCINATE; Company: Glaxosmithkline; Submission Status: Approval; Submission Classification: Labeling; Application Number: 020132

Company
GLAXOSMITHKLINE
Keywords
GLAXOSMITHKLINE